News from intrexon corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Bloomberg:RTRKS,RICS:RTRKS)

Feb 27, 2015, 16:30 ET
Intrexon Corporation logo.

Intrexon to Acquire Okanagan Specialty Fruits

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has entered into an agreement to acquire Okanagan...

Feb 23, 2015, 07:00 ET

Intrexon to Announce Fourth Quarter and Full Year 2014 Financial Results on Monday, March 2, 2015

 Intrexon Corporation (NYSE: XON) today announced it will release fourth quarter and full year 2014 financial results after the market closes...

Feb 13, 2015, 07:15 ET
Intrexon Corporation logo

Living Biofactories in Your Prescription Bottle?

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has entered into a definitive agreement to acquire...

Jan 27, 2015, 09:00 ET

Intrexon Announces Closing of $116 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today the closing of its previously announced public offering of...

Jan 26, 2015, 08:30 ET
Intrexon Corporation logo

Intrexon to Acquire Remaining Stake in Exemplar Genetics

Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has launched a tender offer to acquire the remaining stake in...

Jan 21, 2015, 20:44 ET

Intrexon Prices Public Offering of Common Stock

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that it has priced its previously announced underwritten...

Jan 20, 2015, 16:02 ET
Intrexon Corporation logo.

Intrexon Announces Proposed Public Offering of Common Stock

Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today it has commenced an underwritten public offering of up to $150...

Jan 13, 2015, 16:24 ET

Intrexon, ZIOPHARM, and MD Anderson in Exclusive CAR T Pact

Intrexon Corporation (NYSE: XON), a leader in synthetic biology and its oncology partner, ZIOPHARM Oncology (NASDAQ: ZIOP), today announced a broad...

Jan 06, 2015, 08:30 ET
Intrexon Corporation logo.

Intrexon to Present at the 2015 J.P. Morgan Healthcare Conference

Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that Randal J. Kirk, Chairman and Chief Executive Officer of...

Dec 04, 2014, 09:00 ET

Intrexon Announces the Appointment of Peter Emtage, Ph.D., as Vice President, Synthetic Immunology

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Peter Emtage, Ph.D., as Vice President,...

Nov 13, 2014, 16:01 ET
Intrexon Corporation logo.

Intrexon Announces Third Quarter 2014 Financial Results

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its third quarter results for 2014.  Business...

Nov 06, 2014, 16:30 ET
Intrexon Corporation logo

Study Demonstrates Automated Laser-based Cell Manipulation with Intrexon's Proprietary LEAP® System

 A new study by scientists at Sanford-Burnham Medical Research Institute, a nonprofit research institution and one of the largest induced...

Nov 06, 2014, 08:30 ET

Intrexon to Announce Third Quarter 2014 Results and Host Conference Call on November 13th

 Intrexon Corporation (NYSE: XON) today announced it will release third quarter 2014 financial results after the market closes on Thursday,...

Oct 03, 2014, 08:30 ET

Histogenics and Intrexon Announce Formation of Exclusive Channel Collaboration for Cartilage Repair Therapies

Histogenics Corporation, a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, and...

Oct 02, 2014, 08:30 ET

Intrexon and Amneal Expand Relationship with Second Product Collaboration

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, and Amneal Pharmaceuticals LLC, the seventh largest generic drug manufacturer...

Sep 05, 2014, 16:36 ET
Intrexon Corporation logo.  (PRNewsFoto/Intrexon Corporation)

Intrexon Announces Filing of Form S-3 Shelf Registration Statement

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that, pursuant to the terms of its recent acquisition of...

Sep 05, 2014, 08:45 ET
Intrexon Corporation logo.  (PRNewsFoto/Intrexon Corporation)

Intrexon Announces the Appointment of Keith Canada as Vice President, UltraVector® Division

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced the appointment of Keith Canada, Ph.D., as Vice President,...

Sep 02, 2014, 08:30 ET

Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced that it has entered into an Exclusive Channel Collaboration...

Aug 14, 2014, 16:30 ET

Intrexon Announces Second Quarter and First Half 2014 Financial Results

 Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its second quarter and first half results for 2014. ...

Aug 12, 2014, 08:30 ET
Intrexon Corporation logo.  (PRNewsFoto/Intrexon Corporation)

Intrexon to Announce First Half and Second Quarter 2014 Results and Host Conference Call on August 14th

 Intrexon Corporation (NYSE: XON) today announced it will release first half and second quarter 2014 financial results after the market...